Immunoassay for detailed analysis of immune−cancer intercellular interactions can achieve more promising diagnosis and treatment strategies for cancers including nasopharyngeal cancer (NPC). In this study, we report a microfluidic live−cell immunoassay integrated with a microtopographic environment to meet the rising demand for monitoring intercellular interactions in different tumor microenvironments. The developed assay allows: (1) coculture of immune cells and cancer cells on tunable (flat or micrograting) substrates, (2) simultaneous detection of different cytokines in a wide working range of 5–5000 pg/mL, and (3) investigation of migration behaviors of mono- and co-cultured cells on flat/grating platforms for revealing the topography-induced intercellular and cytokine responses. Cytokine monitoring was achieved on-chip by implementing a sensitive and selective microbead-based sandwich assay with an antibody on microbeads, target cytokines, and the matching fluorescent-conjugated detection antibody in an array of active peristaltic mixer-assisted cytokine detection microchambers. Moreover, this immunoassay requires a low sample volume down to 0.5 μL and short assay time (30 min) for on-chip cytokine quantifications. We validated the biocompatibility of the co-culture strategy between immune cells and NPC cells and compared the different immunological states of undifferentiated THP-1 monocytic cells or PMA-differentiated THP-1 macrophages co-culturing with NP460 and NPC43 on topographical and planar substrates, respectively. Hence, the integrated microfluidic platform provides an efficient, broad-range and precise on-chip cytokine detection approach, eliminates the manual sampling procedures and allows on-chip continuous cytokine monitoring without perturbing intercellular microenvironments on different topographical ECM substrates, which has the potential of providing clinical significance in early immune diagnosis, personalized immunotherapy, and precision medicine.
Microfluidic fabrication technologies are increasingly used to produce functional anisotropic microstructures for broad applications. However, the limited flow manipulation methods hinder the production of intricate microstructure morphologies. In this work, we introduce CeyeHao, an artificial intelligence–driven flow programming methodology for designing microchannels to perform unprecedented flow manipulations. In CeyeHao, microchannels containing hierarchically assembled obstacles are constructed, offering more than double flow transformation modes and immense configurability compared to state-of-the-art methods. An AI model, CEyeNet, predicts the transformed flow profiles, reducing computation time by up to 2700 folds and achieving up to 97 and 90% accuracy with simulated and experiment results. CeyeHao facilitates microchannel design in both human-guided and automatic modes, enabling creation of flow morphologies with highly regulated geometries and elaborate artistic patterns, along with precise topology manipulation of multiple streams. The superior flow manipulation capability of CeyeHao can facilitate broad applications from complex microstructure fabrication to precise reaction control.
Biophysical properties of single cells serve as label-free, noninvasive biomarkers for phenotyping. However, most techniques measure quantities dependent on multiple biophysical properties rather than individual ones, limiting their biological/clinical relevance. Here, we present a single-cell biophysical phenotyping technique that quantifies size (Dc) and elastic modulus (E) of cells deforming at different levels along constriction microchannels. A physical model is developed to resolve features of multiple deformation stages into Dc and E. Parallel-channel device design achieves a reasonably high throughput of ∼104 cells/min. The measurement employs lock-in amplification-assisted electrokinetic sensing via embedded electrodes across three channel sections with varying constriction widths, inducing distinct cell deformations. We demonstrate the technique by profiling normal and cancerous breast cell lines (MCF-10A, MCF-7, and MDA-MB-231), as well as drug-treated cancer cells (cytochalasin D, cetuximab, and lysophosphatidic acid). The biophysical phenotyping enables cell classification with high accuracy (>95.45% via principal component analysis; >97.32% via machine learning). This approach offers robust and high-throughput cell classification, with potential applications in basic research and clinical diagnostics.
We present a microfluidic platform for real-time, label-free cytometry and sorting of single cells based on intrinsic biophysical properties. The system integrates impedance-based electrokinetic sensing with a constriction microchannel architecture to induce controlled deformation during cell transit. Electrical signals captured via lock-in amplification are processed through a parallel software pipeline incorporating deep learning algorithms for event detection and feature extraction. A biomechanical model enables conversion of raw signal features into cell size and whole-cell elasticity, validated against imaging measurements. Experimental results demonstrate accurate phenotyping and sorting of live and dead MCF-7 cells, achieving sorting accuracy of 84%. This approach offers a cost-effective and scalable solution for biophysical analysis, with potential applications in liquid biopsy, disease diagnostics, and personalized medicine.